Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients
Clinical trial NCT04352465 · UNKNOWN
Trial details
- NCT number
- NCT04352465
- Sponsor
- Azidus Brasil
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2020-06-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.